Diamyd Medical AB (DMYDb)

Stockholm
30.500
+0.740(+2.49%)
  • Volume:
    128,533
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    29.260 - 30.500
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0005162880
  • S/N:69013573

DMYDb Overview

Prev. Close
29.76
Day's Range
29.26-30.5
Revenue
360K
Open
29.72
52 wk Range
21.5-74.7
EPS
1.07
Volume
128,533
Market Cap
2.18B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
186,300
P/E Ratio
28.58
Beta
2.09
1-Year Change
39.27%
Shares Outstanding
71,569,796
Next Earnings Date
Oct 06, 2021
What is your sentiment on Diamyd Medical AB?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy

Diamyd Medical AB Company Profile

Diamyd Medical AB Company Profile

Employees
12
Market
Sweden

Diamyd Medical AB (publ) engages in developing therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunomodulating diabetes vaccine for the treatment of type 1 diabetes and latent autoimmune diabetes, which is in Phase IIb clinical development; and Remygen, an oral regenerative and immunomodulatory drug candidate for the treatment of autoimmune and type 2 diabetes, which is in Phase I/II clinical development. Diamyd Medical AB (publ) was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. The company was founded in 1984 and is based in Stockholm, Sweden.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.